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Abstract
Zebrafish (Danio rerio) has recently emerged as a powerful experimental model in drug discovery and environmental
toxicology. Drug discovery screens performed on zebrafish embryos mirror with a high level of accuracy the tests usually
performed on mammalian animal models, and fish embryo toxicity assay (FET) is one of the most promising alternative
approaches to acute ecotoxicity testing with adult fish. Notwithstanding this, automated in-situ analysis of zebrafish
embryos is still deeply in its infancy. This is mostly due to the inherent limitations of conventional techniques and the fact
that metazoan organisms are not easily susceptible to laboratory automation. In this work, we describe the development of
an innovative miniaturized chip-based device for the in-situ analysis of zebrafish embryos. We present evidence that
automatic, hydrodynamic positioning, trapping and long-term immobilization of single embryos inside the microfluidic
chips can be combined with time-lapse imaging to provide real-time developmental analysis. Our platform, fabricated using
biocompatible polymer molding technology, enables rapid trapping of embryos in low shear stress zones, uniform drug
microperfusion and high-resolution imaging without the need of manual embryo handling at various developmental stages.
The device provides a highly controllable fluidic microenvironment and post-analysis eleuthero-embryo stage recovery.
Throughout the incubation, the position of individual embryos is registered. Importantly, we also for first time show that
microfluidic embryo array technology can be effectively used for the analysis of anti-angiogenic compounds using
transgenic zebrafish line (fli1a:EGFP). The work provides a new rationale for rapid and automated manipulation and analysis
of developing zebrafish embryos at a large scale.
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Introduction
Small model organisms offer advantages over cell lines and
isolated tissues by providing analysis under normal physiological
milieu of the whole organism [1–3]. This opens up enhanced
analytical capabilities that cannot be easily replicated in vitro using
isolated primary cells, cell lines and/or tissue cultures [1–3]. In this
context, zebrafish (Danio rerio) is gaining considerable interest as
a convenient experimental model. Small size, optical transparency
of organs and simple husbandry make D.rerio embryos, eleuthero-
embryos and juvenile stages as the ideal models for large scale
pharmacological and toxicological studies [2,3]. Abundant exper-
imental techniques and molecular tools have facilitated the use of
zebrafish as the model of choice for studies of many human
diseases [3]. It has already been reported as a powerful and
versatile vertebrate system that can facilitate accelerated drug
discovery [3–5]. Furthermore, fish embryo toxicity assay (FET) is
one of the most promising alternative approaches to classical
ecotoxicity testing with adult fish, already standardized at the
international level according to OECD and US EPA guidelines
[6–8].
Paradoxically, analysis of small model organisms such as fish
embryos and juveniles in a high-throughput and high-content
manner is still a challenging task [1,2,9]. This is mostly due to the
inherent limitations of conventional techniques and the fact that
metazoan organisms are not easily susceptible to laboratory
automation. Despite some emerging progress in cytometric large
particle analysis, the embryo handling and treatment are mainly
performed manually and bioassays carried out under sub-optimal,
static microtiter plate conditions [1,7,9–11].
Not surprisingly, implementation of miniaturized chip-based
systems for in-situ analysis of small model organisms is attracting
a rapidly growing interest [1,12]. Mushrooming reports have
recently showed automated manipulation and immobilization of
micron-sized organisms such as C.elegans and D.melanogaster [1,12–
15]. Development of chip-based devices able to automatically
manipulate millimeter and sub-millimeter scale organisms such as
fish and amphibian embryos is, however, still in its infancy but can
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screening [1]. Several attempts have been recently made and
involved (i) embryo culture in segmented flow inside the PTFE
tubes [16]; (ii) use of electrowetting-on-dielectric (EWOD)
technique for transport of live zebrafish embryos in small droplets
[17]; (iii) the use of a glass microwell flow-through system [18]; (iv)
the development of a polymeric microwell array with integrated
gradient generator [19]; and finally (v) vertebrate automated
screening technology (VAST) for automated manipulation and
imaging of several days old larvae in a glass microcapillary
mounted on a 3D robotic manifold [20]. These approaches have
recently been reviewed [1] and none of them allow for a high-
speed, automated and gentle hydrodynamic positioning, trapping
and long-term immobilization of large numbers of single
vertebrate embryos for real-time developmental analysis [1].
In this work, we for the first time describe an innovative
miniaturized embryo array that registers each embryo throughout
the analysis in a single addressed location, provides highly
controllable fluidic microenvironment and post-analysis specimen
recovery. In contrast to any previously described zebrafish chips, it
allows for a one-step automatic loading, hydrodynamic position-
ing, trapping and long-term immobilization of single embryos
inside the microfluidic chips. The miniaturized devices were
fabricated using a high-speed laser fabrication system adequate for
both rapid prototyping and medium scale production. Important-
ly, we also for first time show that microfluidic embryo array
technology can be effectively used for the analysis of anti-
angiogenic compounds using transgenic zebrafish line (fli1a:EGFP)
[21]. The work provides a new rationale for rapid and automated
manipulation and analysis of developing transgenic zebrafish
embryos using microfluidic devices at a large scale.
Materials and Methods
Chip Design and Fabrication
The microfluidic chip was designed and modeled using
CorelDraw X4 (Corel Corporation, Ontario, Canada) and
SolidWorks 2011 (Dassault Systemes SolidWorks Corp, Concord,
MA, USA) CAD packages. Subsequent prototyping and fabrica-
tion was performed using a non-contact, 30 W CO2 laser cutting
system equipped with a High Power Density Focusing Optics
(HPDFO)
TM (Universal Laser Systems, Scottsdale, AZ, USA). The
master shape was laser cut in 1.5 mm thick poly-methyl
methacrylate sheet (PMMA/Acrylic; PSP Plastics Ltd, Auckland,
New Zealand) to form the integrated channel and trapping region
structure (Figure 1). The master was then thermally bonded to
a2 5 67562 mm PMMA sheet at 110uC for up to 2 hours in a fan
assisted oven. A uniform mechanical force was applied using two
mini C-clamps to provide equal force distribution during PMMA
layer bonding. The bonded PMMA master was then used for
replica molding in poly(dimethylsiloxane) (PDMS; Sylgard 184;
DowCorning Corp, Midland, MI, USA), as described earlier [22].
Briefly, the PDMS was mixed at a 10:1 (w/w) ratio of elastomer
base to curing agent and degassed at 40 Torr to remove any
residual air bubbles. PDMS was then poured on a PMMA master
to achieve approximately 5 mm thickness and cured thermally at
80uC for up to 1 hour. Cured PDMS devices were mechanically
diced and bonded to the glass microscope slides using oxygen
plasma surface activation. Tubing interconects were manually
bored using an appropriate stainless steel punch hole, as described
earlier [22,23].
Computational Analysis and Multiphysics Modeling
In order to estimate the velocities throughout the flow domain,
shear stress over the chorion surface, diffusion of the drug/dye and
the immobilization force that holds embryos inside the traps, two-
dimensional (2D) and three-dimensional (3D) models of the device
were created with virtual embryos as spherical structures inside the
traps. The simulation was performed using Gambit 2.3 software
(Fluent, Lebanon, NH, USA) to create the geometry and mesh
generation. Finite-volume based Fluent 6.3 software (Fluent,
Lebanon, NH, USA) was subsequently used to solve the associated
differential equations governing the balance of mass, momentum,
chemical species, as given below:
+: ~ U U ~ 0: ð1Þ
r (~ U U: +) ~ U U~{ +Pzm+2~ U Uzrgz ð2Þ
LC
Lt
z (~ U U: +)C~ D +2C ð3Þ
where, ~ U Uand P are the velocity vector and the pressure of the flow,
C is the concentration of species, r, m and D are the density,
dynamic viscosity and diffusion coefficient of chemical species, t is
time, and gz is the gravitational acceleration.
Boundary conditions consisted of a flow rate between 100–
2000 ml/min at the inlet and a pressure set to 0 Pa at the outlet.
The other surfaces including the bottom, top and sidewalls of the
channels as well as the embryo chorions were set to no-slip
condition. The highest Reynolds number obtained at the
maximum flow rate is
r  U UD hydraulic
m ~ 998|0:0055|0:0017
0:001 ~19, indicat-
ing the laminar characteristics of our miniaturized system.
Chip Setup, Loading and Operation
The device was directly connected to the external high-precision
Miniplus Evolution peristaltic pump equipped with a MF1 pump
head (Gilson Inc, Middleton, WI, USA) using 1/160 polyurethane
tubing (Cole-Parmer Instrument Company, Vernon Hills, Illinois,
USA) with an internal diameter allowing for the free passage of
zebrafish embryos. The PVC calibrated tubing (1.02 mm ID;
Gilson Inc) was mounted inside the pump to provide flow rates
over the desired range (100–2000 ml/min). Devices were primed
with 70% ethanol (v/v) to help wet the PDMS and reduce the
nucleation and persistence of air bubbles. Chips then were filled
with standard E3 fish medium. The chips were positioned on
a microscope stage and embryos with intact chorion between 6–24
hours post-fertilization (hpf) were loaded by aspirating single
embryos one by one at the flow rates of up to 2 ml/min. The
pump was adjusted to provide a continuous negative pressure
(nominal withdrawal mode at up to 2 ml/min). Embryo loading
and trapping was confirmed microscopically. After loading, the
chips were placed on a microprocessor-controlled heating stage
(IKA Works, Petaling Jaya, Malaysia) and connected to a 250 ml
glass reservoir (Schott AG, Mainz, Germany) mounted inside
a waterbath (Julabo Labortechnik GmbH, Seelbach, Germany).
Heated medium was recirculated in a closed loop perfusion for up
to 72 hours allowing for an optimal embryo development
temperature of about 28.560.5uC inside the PDMS chip.
Embryo Array Technology
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Adult zebrafish were kept in a 14 hour light, 10 hour dark cycle
fish facility and fed twice daily with artemia and once daily with
dry feed. Wild-type zebrafish (Danio rerio (AB line; Zebrafish
International Resource Center, Oregon, Eugene, OR, USA)
Animal research was conducted with approval from The
University of Auckland Animal Ethics Committee (approval ID
R661/1) [24].
Figure 1. Microfluidic embryo array chip for automatic trapping and immobilization of zebrafish embryos: A) CAD drawing showing
the design of the serpentine embryo array device; B) Magnified detail section with the hydrodynamic deflector, embryo trap, and a suction channel;
C) Photograph showing the assembled device moulded in the elastomer PDMS and bonded to the glass slide; D) Microphotograph showing a section
with six embryo traps; E) Schematic showing the off-chip interconnections and hardware components actuating the microfluidic device. For details
refer to the Materials and Methods. Blue arrows depict the direction of fluid flow direction.
doi:10.1371/journal.pone.0036630.g001
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Zebrafish embryos were obtained from random pair-wise
mating and natural spawning. Embryos were then collected in
embryo medium E3 and rinsed to remove any debris and dead
embryos. Embryos were kept at 28.560.5uC in E3 medium and
developmentally staged as described earlier [24,25]. The embryos
of 4–6 and/or 24 hpf were selected for experiments. Various
parameters were analyzed according to: (i) Lethal endpoints
(cumulative mortality): coagulation, tail detachment, lack of somite
formation; (ii) Sublethal developmental endpoints: development of
eyes, spontaneous movement, heartbeat and blood circulation,
pigmentation, formation of edemata; (iii) Endpoints of teratoge-
nicity: malformation of the head, malformation of tail, yolk
deformation general growth retardation [6,7,26]. Hatchling
potential and time was also evaluated [6,7]. Following all
experiments, the hatched eleuthero-embryos were euthanized at
220uC. For the mass transfer experiments where preservation of
viability was not important the chips were perfused with 0.04%
Trypan Blue dye (Life Technologies Corp, CA, USA) in tap water.
Zebrafish in vivo Angiogenesis Assay
Friend leukaemia integration 1a transgenic zebrafish line
(fli1a:EGFP)
y1 expressing enhanced green fluorescent protein
(EGFP) in the vasculature throughout the development of
zebrafish embryos was used [21]. The 4 hpf (hours post-
fertilization) embryos were collected and placed in 5 ml of E3
medium supplemented with penicillin/streptomycin (Life Tech-
nologies Corp) and maintained in the dark overnight at the 22uC
to slow down the process of embryogenesis. Subsequently all non-
fertilized embryos were removed and embryos at 16 hpf stages
were loaded on each chip. Up to 20 embryos per chip were loaded
using E3 medium as a carrier. Following embryo docking and
immobilization the E3 medium in each chip was replaced with the
E3 solution supplemented with either 1 mM of selective VEGFR
inhibitor AV951 (Tivozanib; AVEO Pharmaceuticals Inc, Cam-
bridge, MA, USA) or vehicle (DMSO, Life Technologies Corp)
[27,28]. The medium was also supplemented with 0.003% 1-
phenyl-2-thiourea (PTU, Life Technologies Corp) to maintain the
optical transparency of the zebrafish embryos. Chips were then
positioned on a heating stage at 28–29uC and continuous closed-
loop perfusion at the flow rate of 100 ml/min was maintained for
the 48 hours. The recirculated medium was heated to the 28–29uC
using miniaturized water bath. A 0.2 mg/ml of Tricaine mesylate
buffered solution was perfused through the chips 15 minutes
before image acquisition. This was maintained only for the
duration of imaging procedures to provide temporary anaesthesia
and inhibit the intrinsic embryo movements during the fluorescent
imaging. A Nikon SMZ1500 fluorescent stereomicroscope
equipped with a DS-U2/L2 camera and standard FITC/GFP
filter cube was used to acquire brightfield and fluorescence images
of developing embryos. Intersegmental vessels (ISV) were analyzed
and counted manually [21]. The complete inhibition was
considered when ISV had extended to the level of the dorsal
longitudinal anastomotic vessel.
Imaging
Time-lapse imaging of developing embryos cultured on chip-
based devices was performed using the Leica MZ7.5 stereomicro-
scope equipped with a Leica DFC295 CMOS camera and
running under the LAS Multitime software (Leica Microsystems,
Wetzlar, Germany). A Nikon SMZ1500 fluorescent stereomicro-
scope equipped with a DS-U2/L2 camera and standard FITC/
GFP filter cube was used to acquire brightfield and fluorescence
images of developing transgenic fli1a:EGFP embryos. Embryo
trapping efficiency and mass transfer experiments were acquired
using the Canon 600D Digital SLR (Canon Inc, Tokyo, Japan)
equipped with a true 1:1 macro lens (Canon EF 100 mm f/2.8
Macro Lens; Canon Inc).
Data Analysis and Controls
Data analysis and presentation was performed using the LAS
(Leica Microsystems); ImageJ (freely available at http://rsb.info.
nih.gov/ij/web page); GraphPad Prism (GraphPad Software, Inc.
CA, USA); SolidWorks 2011 (Dassault Systemes SolidWorks
Corp) and Fluent 6.3 (Fluent) software. The Student’s t-test was
applied for comparison between groups using MS Excel (Micro-
soft, USA) and GraphPad Prism (GraphPad Software) with
significance set at p,0.05.
All control measurements are provided in detail in the Figure
legends, where appropriate, but in general involved making direct
comparisons between the chip-based devices and static 24-well
microtiter plates or 60 mm Petri dishes (Nalge Nunc Inc, NY,
USA).
Results
Design Rationale for Hydrodynamic Embryo Trapping
There is a noticeable lack of technologies for automated
positioning, trapping and long-term immobilization of large
numbers of single zebrafish embryos that can be interfaced with
time-lapse imaging, video-microscopy and most importantly
register position of each embryo throughout the analysis in a single
location. The major obstacle against manipulation and arraying of
millimeter-sized embryos in perfusion chip-based devices is linked
to their substantial mass (850–1050 mg for zebrafish embryos),
which leads to rapid gravitational-induced sedimentation and high
momentums of translational and rotational movements. Our
device was designed to overcome the challenges of large particle
manipulation on Lab-on-a-Chip systems. The design was based on
a 2D (one-layer), optically transparent system fabricated in
a biologically compatible PDMS (Figure 1). The chip consisted
of three integrated modules: (i) the main twisted shaped channel
for embryo loading and medium perfusion, (ii) an array of 48
embryo traps in 12 consecutive rows, with hydrodynamic
deflectors for enhanced embryo positioning, (iii) an array of small
suction channels that connect traps with the main channel and
provide direct hydrodynamic force to drag the embryos into the
traps (Figure 1). The internal volume of the device was
approximately 825.9 ml while the volume of a single trap was
2.77 ml. The advantage of the design is that it can be actuated
under negative pressure with the output port connected to
a microprocessor-controlled peristaltic pump and re-configurable
external plumbing to open or closed-loop perfusion circuits
(Figure 1). In the closed loop perfusion the device can be actuated
from the reservoir’s volume of 1–2 ml. The perfusion fluidic lines
can also be shortened and the valve can be configured to use
tubing of very small diameter just for the drug perfusion. We
calculated that the total volume of the fluid system can be reduced
down to approximately 3 ml when operated in a closed loop-
perfusion.
The chip was designed to allow for automatic and passive
trapping of individual embryos using only hydrodynamic forces
(Figure 2A–C, Movie S1). For this purpose, the embryos were
loaded on a chip one-by-one in approximately five-second
intervals using a flexible 1.5 mm ID suction tube connected to
a storage vessel. After entering the device, the embryos rolled on
the bottom surface of the main channel under the influence of
drag force. The dimensions of the channel allowed for a free
Embryo Array Technology
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36630Figure 2. Principles and validation of embryo trapping performance: A) A 3D cartoon showing the embryo trapping principles: 1-embryo is
aspirated from the storage vessel and injected into the main channel, 2-hydrodynamic forces guide the embryo into the trap, 3–4-next embryo is
introduced and rolls on the previous one towards the next available trap, 5–6-the process is repeated till all the traps are filled with embryos, while
Embryo Array Technology
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S1). Embryos approaching the empty traps were affected by the
cross flow passing through the suction channels that changed their
trajectory directly towards the traps (Figure 2A–C, Movie S1). The
transverse displacement of the rows between consequent rows with
the magnitude of half of the distance between two neighboring
traps, generated streamline profiles enhancing the rapid docking of
embryos inside the traps (Figure 2B). The embryos experienced
hydrodynamic drag forces ranging from 1.5E–07 to 4.0E–08 N
when perfused at the volumetric flow rate of 0.4 ml/min
(Figure 2D, Figure S1). Importantly, the size and shape of the
traps were designed to assure: (i) single embryo occupancy, and (ii)
unobstructed passage of other embryos in the main channel
following docking. Moreover, specially designed hydrodynamic
deflectors at the end of each row considerably enhanced the
change of particle trajectory directly towards the traps (Figure 1
and 2A–B). Interestingly, the flow velocity was highest across the
first trap of each row (Figure 2B, Figure S1). This phenomenon
reinforced the trapping effect, as the serpentine shape of the device
resulted in an increased velocity of the embryos (1.5–2 times
higher) at the turn sections of the main channel.
Subsequent embryos introduced into the device rolled freely in
the main channel towards the next available traps (Movie S1). The
process was repeated until all traps were occupied. Hydrodynamic
forces alone were sufficient to achieve over 80% trapping
efficiency when device was placed on horizontal microscope stage,
confirming the computational assumptions (Figure 2E–F, Figure
S1) [29]. When the device was placed on an elevated stage (tilt
angle ranging from 11.25–45 degrees) the combined hydrody-
namic and gravitational pull obtained nearly 100% trapping
efficiency irrespectively of the flow rates applied (Figure 2F–G,
Figure S1). Over 98%62.5 of trapped embryos retained their
position during the course of even long-term experiments (ca. 72
hours). Manipulation and complete tilting of the device during the
perfusion process did not lead to dislodgment of any embryos.
Importantly, the one-step loading and trapping process was
straightforward and did not require any active on-chip or off-chip
actuators apart from a single pump. After loading, the device could
be disconnected by closing both input and output valves. In this
scenario, however, embryos could only be held in traps by
gravitational forces when the chip was tilted (Figure S1). This
feature allowed for transport and/or reconnection to different
hardware during the course of experiments.
The design achieved one-embryo-in-one-trap for convenient
address designation and encoding to each embryo. As such it
greatly facilitates: (i) staining or treatment without displacing the
embryos; (ii) highly controllable fluidic microenvironment for
analysis under continuous perfusion; (iii) spatial segregation of
developing embryos to avoid embryo-to-embryo interaction; (iv)
future applicability of customized image and data analysis
software, allowing simple geometric designation of each embryo.
None of these features can be achieved by using simple Petri dish
approach.
Single Embryo Microperfusion
Efficient exchange of circulating medium and also the uniform
delivery of drugs and dyes to immobilized zebrafish embryos is an
important consideration for long-term microperfusion studies in
ecotoxicology and drug discovery. We observed that after docking,
hydrodynamic forces pulled the embryos towards the small suction
channels raising concerns about the microperfusion performance
(Figure 3A). Computational fluid dynamic simulations indicated,
however, that even though the embryos rested directly on the
inlets of suction channels, their rectangular cross sections still
permitted for a considerable flow passing around the embryos
(Figure 3B). These results on mass transfer inside the device were
next validated experimentally using 0.04% Trypan Blue dye as
a model probe while the perfusion flow rate was set to 0.4 ml/min.
Figure 3C depicts both the simulated and real-world assessments
of the mass transfer across the array fully loaded with a population
of 48 zebrafish embryos. We found that dye freely entered all
occupied traps and the complete dye exchange across the whole
device occurred within 90 s (Figure 3C and D, Figure S2). This
could be further accelerated to below 15 s simply by increasing the
flow rate up to 2 ml/min (Figure 3D). Next we validated the dye
delivery to each embryo across by perfusing the chip with
a solution of 0.04% Trypan Blue and subsequently quantifying the
intensity of the stained embryos (Figure 3E and F) after a washing
step with E3 medium. This revealed uniform labeling with
occasional higher intensities detected due to the heterogeneous
sizes within the embryo population (Figure 3E and F). The above
experiments were also performed using tetramethylrhodamine
methyl ester (TMRM) fluorescent probe yielding comparable
results. Our data demonstrated a strong correlation with the
computational models that guided the design of the device
providing further evidence that hydrodynamic trapping principles
allow for both robust immobilization of the fish embryos inside the
traps and also efficient medium exchange and uniform drug
delivery across the miniaturized array.
The ability to perform continuous perfusion experiments
without displacing the embryos is an important consideration in
environmental toxicology in particular. Static tests performed
traditionally in Petri dishes represent the simplest and cheapest
way to assess toxicity of chemicals [7]. They can be, however,
inadequate to test toxicity of many compounds because of their
adsorption, degradation, metabolic inactivation, shortage of
oxygen, uncontrolled changes in medium pH. All these condition
can severely constrain the appropriateness of static exposure
utilized in standard FET tests [7]. Therefore, it has been recently
postulated by Lammer et al that flow-through/dynamic acute tests
should become a preferable choice for toxicants analysis [7].
Furthermore as suggested by Lammer et al yet another drawback
of static FET is that these use only very small volumes of test
substance which make chemical confirmatory analyses tremen-
dously difficult [7]. By implementing a perfusion system, larger
volumes of medium can be collected for confirmatory chemical
analysis such as the metabolic degradation of compounds. This is
expected to bring greater quality control and data for a compre-
hensive interpretation of toxicity results [7].
the hydrodynamic forces keep embryos securely docked for the duration of experiments; B) Velocity contours (m/s) across the device at the vertical
middle plane (0.75 mm from the bottom of the channel) when perfused at a flow rate of 0.4 ml/min. Due to the computational limitations only first
six row were simulated; C) The pressure drop (Pa) across the traps when perfused at a flow rate of 0.4 ml/min; D) Analysis of the drag force (N)
applied on embryos when device is perfused at a flow rate of 0.4 ml/min; E) Microphotograph showing a six row section of the device completely
filled with zebrafish embryos, when perfused at a flow rate of 0.4 ml/min according to the simulations above; F) Experimental validation of embryo
trapping efficiency at varying volumetric flow rates and tilt angles of the device; G) Photographs of a device mounted 11.25 degrees tilted angle
stage used to perform trapping efficiency experiments as denoted in F). Blue arrows depict the direction of fluid flow and embryo movement along
the serpentine channel.
doi:10.1371/journal.pone.0036630.g002
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36630Figure 3. Validation of embryo microperfusion and drug delivery inside the chip: A) Microphotograph showing a single immobilized
zebrafish embryo (circa 16 hpf); B) 3D streamlines of fluid around the embryos colored by flow velocity (m/s) obtained by computational fluid
dynamic simulations as the fluid enters two traps occupied by docked embryos. Perfusion was simulated at a volumetric flow rate of 0.4 ml/min; C)
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with the drug followed by the rapid medium exchange without
disturbing the embryo position. This can be of particular
importance to precisely control the transcriptional activation of
target genes using inducible transgenes such as Tet-On Tetracy-
cline-Inducible Gene Expression System. Moreover, the pulsed
drug delivery can be exploited for the temporary delivery of toxins
and/or anaesthetic agents to evaluate short-term exposures to high
dosages, followed by the embryo development in drug free
medium. Also the delivery of cell permeable fluorescent probes can
be greatly facilitated by their quick wash out to reduce the
fluorescent background during subsequent image acquisition.
Microenvironment for Long-term Embryo Culture
To demonstrate the feasibility for developmental analysis of
zebrafish embryos over extended periods of time, we next
performed numerical simulations to estimate both the flow
velocity and the extent of shear stress exerted over embryos.
Firstly, a 3D model of the entire device was built and analysis of
flow profile obtained by computational fluid dynamic simulations
across the fully loaded device. The embryos were simulated as
rigid, not deformable spheres (Figure 4A). The distribution of
shear stress inside the traps was then obtained from a 3D model
(Figure 4B). The results indicated that the embryos encountered
an average shear stress ranging from 1.83E–2 to 4.60E–2 Pa at the
perfusion rate of 0.4 ml/min (Figure 4B and C). A maximum
shear stress of 6.13E-2 Pa was to be experienced only by the
embryos located in the first trap of each row (Figure 4B and C).
This supported the notion that due to the nature of the flow inside
the miniaturized trapping system the embryos will be kept within
a low shear stress microenvironment. In this regard, we previously
extensively explored signaling events associated with single cells
under a range of flow induced mechanical loads [23,30]. Our
current results indicate that the trapped embryos generally
experienced a shear stress at least two orders of magnitude lower
than values reported to trigger cell signaling events [23,30].
Moreover, in contrast to cells, embryos are protected by a robust
physical barrier (chorion membrane) and therefore we anticipate
that shear stress effects on developing embryos are negligible.
Accordingly, we next validated these assumptions by performing
a long-term culture of zebrafish embryos perfused on a chip at
varying flow rates of 0.4 to 2 ml/min for up to 72 hours
(Figure 4D, Figure S3). We observed the normal and very uniform
development of all embryos immobilized across the array
(Figure 4D, Figure S3). Furthermore, during the standard
ecotoxicological FET test period of up to 72 hours, we did not
notice any discernible phenotypic effects irrespectively of the
magnitude of flow rates. The cumulative survival of embryos and
eletheuro-embryos cultured on chip for up to 72 hours was over
95% with the exception of a chip kept at a static regimen
(Figure 5A). In the latter case, the high mortality amongst the
hatched eletheuro-embryos was most likely due to the higher
metabolic rate of hatched stages and oxygen deprivation when
insufficient exchange of medium in the chip was present
(Figure 5B). Interestingly, the hatching time and hatching success
of eletheuro-embryos were inversely proportional to the volumet-
ric flow rate (Figure 5C). We observed, however, that this could be
dramatically improved when perfusion was disengaged at 72 hours
(Figure 5D). Noticeably, the microperfusion culture did not slow
down the embryo development process and our data indicate that
following the chip disconnection, embryos immediately com-
menced the hatching process with up to 6.5 fold increase in
number of hatched stages over only 2 hours (Figure 5D). This
combined with the results from the static chip (where hatching
success was comparable to the control 60 mm Petri Dish vessels)
indicates that hydrodynamic immobilization rather than mechan-
ical constriction inside the traps can somehow arrest the fish
hatching process at the higher flow rates (Figure 5D). Based on our
results, we postulate that our design is particularly suitable for the
bioassay test period of up to 48–72 hours. When the hatching time
and success is of importance, perfusion should be performed at
much lower rates that enable widespread embryo hatching while
preserving sufficient medium exchange to support survival of the
eletheuro-embryo stages. Further studies are required to rule out
any undetected and long-term effects that can become visible
following recovery of juvenile stages.
Indeed, the chip design offered the capability to recover both
embryos and swimming eletheuro-embryo stages. The recovery
was obtained using a reversed flow leading to the hatched stages
being collected from the inlet port (Figure S3). Otherwise the
hydrodynamic forces overcame the swimming behavior and
attracted eletheuro-embryos back to the trapping region (Figure
S3). No mechanical damage to the recovered embryos was
observed.
On-chip Zebrafish in vivo Angiogenesis Assay
Zebrafish has recently emerged as an innovative, whole animal
model for accelerated screening of small molecule drugs that affect
blood vessel formation (angiogenesis) [21,31,32]. The optical
transparency of embryos allows for convenient microscopic
visualization of characteristic patterns of intersegmental vessels
(ISV). This can be reportedly used as a surrogate bioassay to
perform primary screens of investigational anti-angiogenic com-
pounds that diffuse into the embryo and induce dose dependent
inhibition of ISV formation [21,31,32].
Following our initial experiments, we set on to validate the
applicability and performance of the microfluidic embryo array
technology technology for the analysis of anti-angiogenic com-
pounds using transgenic zebrafish line (fli1a:EGFP)
y1 [21,27].
Fli1a:EGFP line expressing enhanced green fluorescent protein in
the vasculature represents a rapid way to visualize development of
ISV formation [21]. In the microperfusion on-chip analysis, the
fli1a:EGFP embryos were loaded onto a chip at 16 hpf stage
before angiogenic sprouting of intersegmental and head vessels
had begun. The embryos were continuously perfused with E3
media containing 1 mM of selective VEGFR inhibitor AV951
(Tivozanib, AVEO Pharmaceuticals Inc) [27,28], and images were
acquired every at 0, 24 and 48 hours intervals. Tivozanib is
a novel, selective, inhibitor targeting of all three vascular
endothelial growth factor (VEGF) receptors 1, 2 and 3 [28]. It
has been designed to maximize the VEGF inhibition with
minimized off-target toxic effects. Figure 6 presents representative
Mass transfer across the simulated (upper panel) and real-world (lower panel) microfluidic array fully loaded with zebrafish embryos. Chip was
perfused with a 0.04% Trypan Blue dye at a volumetric flow rate of 0.4 ml/min; D) Experimental analysis of the time needed for a complete dye
exchange across the whole device (12 rows) at varying flow rates 0.1–2 ml/min.; E) Validation of the dye delivery to each embryo across the
microfluidic array. Chip was perfused with a 0.04% Trypan Blue dye at a volumetric flow rate of 0.4 ml/min for up to 4 minutes. Trypan Blue was then
replaced with medium; F) Intensity of dye across each embryo obtained by image analysis of the experiments in E). Red line denotes the average
staining intensity. Blue arrows depict the direction of fluid flow and embryo movement along the serpentine channel.
doi:10.1371/journal.pone.0036630.g003
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fluorescent stereomicroscopy for AV951-induced inhibition of ISV
formation.
We demonstrated that it is possible to automatically load
transgenic zebrafish embryos into the microfluidic device and
continuously perfuse them with media containing anti-angiogenic
drug (Figure 6). Complete inhibition of ISV was achieved during
close-loop microperfusion on chip as shown in Figure 6. The non-
stimulated (control) fli1a:EGFP embryos developed normal
vasculature as evidenced by the presence of characteristic patterns
of intersegmental vessels (Figure 6). The data shows that the novel
quinolone-urea derivative and selective VEGFR inhibitor AV-951
(Tivozanib, AVEO Pharmaceuticals Inc) is a very effective
inhibitor of angiogenesis (Figure 6) [28].
The optical transparency and embryo immobilization allowed
for convenient ISV imaging without the need for re-focusing and
specimen re-positioning. Address designation to each embryo
during analysis substantially accelerated the data acquisition in
contrast to conventional Petri dish assays. Moreover, the drug
exchange and rapid delivery of the anesthetic Tricaine are
performed automatically within seconds without embryo dislodg-
ment or need for repetitive pipetting. This allows for prospective
automation at a large scale. We postulate that the microfluidic
embryo arrays could form the basis of an automated in vivo assay
Figure 4. Assessment of microenvironmental conditions inside the chip: A) 3D streamline of flow obtained by computational fluid dynamic
simulations across the fully loaded device. Perfusion was simulated at a volumetric flow rate of 0.4 ml/min; B) Contours of shear stress (Pa) exerted on
embryos across the whole device. There sections of the chip (upper, middle and lower part) are magnified for clarity. Perfusion was simulated at
a volumetric flow rate of 0.4 ml/min; C) Performance curves of the chip as a function of the volumetric flow rate; D) Time-lapse images of developing
zebrafish embryos collected every 24 hours. Embryos were loaded on a chip at the volumetric flow rate of 2 ml/min. Subsequently the chip was
perfused at a rate of 0.4 ml/min for up to 72 hours.
doi:10.1371/journal.pone.0036630.g004
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intelligent pattern recognition algorithms, fluorescent ISV signals
in immobilized transgenic embryos could be automatically
quantifiable in a high-throughput fashion [33–35].
Discussion
Automated and high-throughput assays on zebrafish embryos
are still largely unavailable [1]. Despite some emerging progress in
cytometric large particle analysis and robotic liquid handling, the
embryo dispensing and treatment are mainly performed manually
and bioassays carried out under sub-optimal, static microtiter plate
conditions. None of currently available technologies allow for a an
automated positioning, trapping, perfusion treatment and long-
term immobilization of large numbers of single embryos for real-
time developmental analysis. The manual sorting, acquiring and
dispensing of embryos using conventional liquid handling
procedures is very cumbersome, time consuming and error prone,
limiting reproducibility and research productivity. There is, thus,
a great need to develop innovative integrated technologies for
automated loading, transport, positioning and long-term immobi-
lization of large, millimeter scale embryos in ecotoxicology, drug
discovery and reproductive medicine [1,7,9].
We therefore envisage that embryo sorting, capture, culture and
analysis in microfluidic system, where the most tasks are
performed automatically without disturbing the embryo, and
without sudden changes to embryo environment, will prove to be
better than conventional static culture. Recent noteworthy reports
by Wielhouwer et al [18] and Yang et al [19] have showed that
fish embryos can develop in a confined microfluidic environment
and that Lab-on-a-Chip devices hold a substantial promise for
miniaturized toxicological analysis. Both studies fell short,
however, of providing the integrated and automated loading,
positioning, long-term immobilization of large number of single
zebrafish embryos [1,9]. Accordingly, we have for the first time
described an innovative miniaturized chip-based embryo array
that provides address designation to each embryo during analysis,
highly controllable fluidic microenvironment and post-analysis
eleuthero-embryo stage recovery. Our innovative technology hits
on a key point associated with the difficulties associated with
manual, slow and non-reproducible laboratory operations during
embryo manipulations and analysis. No such technology for
embryo/organism-based screening exists at the moment.
In contrast to any previously described technologies, our device
creates a dynamic embryo arrays that allows to: (i) transport
embryos, (ii) immobilize them for convenient imaging, (iii)
continuously deliver reagents and drugs under perfusion while
Figure 5. Development of zebrafish embryos on a chip: A) Cumulative survival (embryos and eletheuro-embryos) perfused on chip at varying
volumetric flow rates. Control denotes static 60 mm Petri Dish; B) Survival of hatched eletheuro-embryos at 72 hours perfused on a chip at varying
volumetric flow rates; C) Hatching success of eletheuro-embryos perfused on chip at varying volumetric flow rates. Control denotes static 60 mm
Petri Dish; D) Hatching time and success of eletheuro-embryos perfused on chip can be dramatically improved when perfusion is disengaged at 72
hours. Control denotes static 60 mm Petri Dish.
doi:10.1371/journal.pone.0036630.g005
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specimens post-analysis for further processing. The trap-and-
release integrated microfluidic system is designed for one-step and
automatic loading, perfusion, analysis and recovery of specimens
all in a single, monolithic integrated device with no moving parts.
Importantly, the design achieves one-embryo-in-one-trap for
convenient address designation to each embryo and the char-
acteristics of the flow allow retrieving a trapped specimen from the
array by displacing it back into the main channel and collecting at
the inlet. Moreover, this design greatly facilitates: (i) staining or
treatment without displacing the embryos; (ii) highly controllable
fluidic microenvironment for analysis under continuous perfusion;
(iii) spatial segregation of developing embryos to avoid embryo-to-
embryo interaction; (iv) applicability of customized image and data
analysis software, allowing address designation to each embryo.
Hydrodynamic techniques have been reportedly used to
manipulate and trap single cells with diameters up to 50 mm
[23,29,36]. Our work establishes new paradigm that that the
underlying hydrodynamic principles can be also employed for
manipulation of large particles with diameter well above 1 mm
and mass often exceeding 1 mg. Notably, we have also simplified
the fabrication process by combining high-speed laser prototyping
with replica moulding in PDMS instead of conventional photo-
lithography techniques. This has facilitated rapid design optimi-
zation and is scalable for a medium scale manufacturing of
miniaturized devices for manipulation of fish embryos.
In closing, our work provides a new rationale for rapid and
automated manipulation of developing zebrafish embryos inside
the new class of miniaturized devices. We envisage that such
technologies, where most tasks are performed automatically
without disturbing the embryo, and without sudden changes to
the embryo environment, will prove to be better and significantly
more productive than conventional static and manual bioassays.
Figure 6. On-chip angiogenesis assay using transgenic zebrafish line: A) The transgenic fli1a:EGFP embryos at 16 hpf were loaded,
immobilized and continuously perfused on a chip with E3 media containing vehicle control (DMSO); B) The transgenic fli1a:EGFP embryos at 16 hpf
were loaded, immobilized and continuously perfused on a chip with a 1 mM of selective VEGFR inhibitor AV951 (Tivozanib, AVEO Pharmaceuticals
Inc). Fluorescent and brightfield images were acquired at 0, 24 and 48 hours intervals. The optical transparency of embryos coupled with
hydrodynamic immobilization on a chip array allowed for convenient microscopic visualization of characteristic patterns of intersegmental vessels
(ISV, white arrows) and their AV951-induced inhibition (red arrows); C) Fli1a:EGFP transgenic embryos arrayed and hydrodynamically immobilized on
a chip-based device. Developing patterns of intersegmental vessels are clearly visible even at the low magnification. Inset shows high magnification
of hatched fli1a:EGFP larva with fully developed pattern of vasculature (white arrows).
doi:10.1371/journal.pone.0036630.g006
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Figure S1 Principles and validation of embryo trapping
efficiency: A) A 3D computer simulation of the flow velocity
across each trap when device is perfused at a flow rate of 0.4 ml/
min. Due to the computational limitations only first six rows were
simulated. Due to mass continuity the flow velocity is highest
across the first trap of each row. This support efficient trapping at
a higher embryo velocities encountered in these regions due to the
serpentine shape of the device; B) Pressure drop across each trap
(Pa) obtained by numerical simulations. Analysis was performed at
a simulated flow rate of 0.4 ml/min. Due to the computational
limitations only first six row were simulated; C–D) Photographs of
stages used to perform trapping efficiency experiments at the 22.5
and 45 degrees tilted angle respectively.
(TIFF)
Figure S2 Validation of microperfusion and drug de-
livery inside the chip. A) Mass transfer across the whole device
(12 rows) fully loaded with zebrafish embryos. Chip was perfused
with a 0.04% Trypan Blue dye at a volumetric flow rate of 0.4 ml/
min. Red section denotes the first 6 rows simulated in Figure 3; B)
Mass transfer across the simulated (left panel) and real-world (right
panel) mesofluidic array without zebrafish embryos. Chip was
perfused with a 0.04% Trypan Blue dye at a volumetric flow rate
of 0.4 ml/min. Red section denotes the first 6 rows simulated in
Figure 3; C) Comparative analysis of the mass transfer in chips
with and without loaded embryos. Chip was perfused with a 0.04%
Trypan Blue dye at a volumetric flow rate of 0.4 ml/min. Due to
the computational limitations only first six rows were simulated.
(TIFF)
Figure S3 Assessment of embryo development inside
the chip. A) Time-lapse images of developing zebrafish embryos
collected every 24 hours. Embryos were loaded on a chip at the
volumetric flow rate of 2 ml/min. Subsequently the chip was
perfused at a rate of 0.4 ml/min for up to 72 hours. Only six rows
are shown due to the limitation of the imaging stereoscopic system.
Note the normal and very uniform development of embryos
hydrodynamically immobilized on the microfluidic array; B–D)
Microphotographs of hatched eletheuro-embryos at 72+ hours on
a chip. Note that chip design offers the capability to recover both
embryos and also swimming eletheuro-embryo stages. The
recovery is best performed at the reversed flow rate when hatched
stages can be collected from the inlet port. Otherwise the
hydrodynamic forces will overcome the swimming behaviour
and attract eletheuro-embryos back to the trapping region as
denoted in D and E.
(TIFF)
Movie S1 One step loading, hydrodynanic trapping and
long-term immobilization of living zebrafish embryos
on a miniaturized chip-based device. Embryos were counter
stained with 0.04% Trypan Blue to improve their visibility during
the video-microscopy. Perfusion was conducted at a volumetric
flow rate of 1 ml/min.
(MP4)
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